Table 8

Fracture Risk Reduction in Response to Therapy.

This table illustrates the direction of change in fracture risk with each type of drug. This does not represent a comparison of the magnitude of fracture risk reduction with different drugs. While all FDA-approved medications have been shown to reduce the risk of spine fracture, only estrogen, alendronate, and risedronate have reduced the risk of hip fracture in randomized placebo-controlled trials.

Lewiecki Clinical and Molecular Allergy 2004 2:9   doi:10.1186/1476-7961-2-9